Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation

Author： Youdim M.B.H. Weinstock M.

Publisher： Elsevier

ISSN： 0161-813X

Source： Neurotoxicology, Vol.25, Iss.1, 2004-01, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective and potent monoamine oxidase type B inhibitors: substituted semicarbazones and acylhydrazones of aromatic aldehydes and ketones

By Bernard S. Paillat C. Oddos T. Seman M. Milcent R.

European Journal of Medicinal Chemistry, Vol. 30, Iss. 6, 1995-01 ,pp. : 471-482

Elsevier

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S. George P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors

By Medvedev Alexei E. Ivanov Alexis S. Veselovsky Alexander V.

Inflammopharmacology, Vol. 11, Iss. 2, 2003-06 ,pp. : 135-143

VSP

Access to resources Recommend Favorite

Effects of selective and non-selective phosphodiesterase inhibitors on tracheal mucus secretion in the rat

By Wagner U. Bredenbroker D. Fehmann H.-C. Schwarz F. Schudt C. Von Wichert P.

European Journal of Pharmacology, Vol. 298, Iss. 3, 1996-03 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Prodrugs of neuron-selective monoamine oxidase inhibitors: amino acid derivatives of 1-(4-aminophenyl)-2-aminopropanes

By Florvall L. Fagervall I. Larsson L.-G. Ross S.B.

European Journal of Medicinal Chemistry, Vol. 34, Iss. 2, 1999-02 ,pp. : 137-151

Elsevier

Access to resources Recommend Favorite